Daily non-political popular news in brief.

Decrease in breast cancer incidence linked to drop in hormone replacement

04-18-2007 · EurekAlert!

A special report in the April 19, 2007, edition of the New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative and the ensuing drop in hormone-replacement therapy among postmenopausal women.

Keywords: decrease, breast, cancer, incidence, linked, drop, hormone, replacement

« Previous | Next »

Similar news on "Decrease in breast cancer incidence linked to drop in hormone replacement":

Drop in breast cancer incidence linked to hormone use, not mammograms
08-14-2007 · EurekAlert!
A recent decline in breast cancer incidence is unlikely to be caused by a decrease in mammography screening, according to a study published online Aug. 14 in the Journal of the National Cancer Institute. It is more likely due to the drop in postmenopausal hormone use.
Similar news · Read more »
Decline in breast cancer cases likely linked to reduced use of hormone replacement
12-14-2006 · EurekAlert!
In 2003, breast cancer incidence in the United States dropped sharply, and this decline may largely be due to the fact that millions of older women stopped using hormone replacement therapy (HRT) in 2002, according to a new analysis led by researchers at the University of Texas M. D. Anderson Cancer Center.
Similar news · Read more »
IMS reaction to report on breast cancer incidence in 2003 in US
04-18-2007 · EurekAlert!
Following a report of the analysis of data from the SEER registries of the NCI, showing that the incidence of breast cancer fell by 6.7 percent in 2003 in the US, and the suggestion that the data might be linked to the decrease in the use of postmenopausal hormones, the IMS advises caution in linking these two trends and recommends that hormone therapy be prescribed whenever indicated.
Similar news · Read more »
Decrease in breast cancer rates related to reduction in use of hormone replacement therapy
04-18-2007 · EurekAlert!
The sharp decline in the rate of new breast cancer cases in 2003 may be related to a national decline in the use of hormone replacement therapy (HRT). Age-adjusted breast cancer incidence rates in women in the United States fell 6.7 percent from 2002 to 2003. Prescriptions for HRT also declined rapidly in 2002 and 2003.
Similar news · Read more »
Breast cancer incidence continues to trend low in 2004; decline supports role of HRT
04-18-2007 · EurekAlert!
An extended analysis of cancer rates reinforces a strong association between use of hormone replacement therapy and increased breast cancer incidence, according to research led by scientists at the University of Texas M. D. Anderson Cancer Center and published in the April 19 issue of the New England Journal of Medicine.
Similar news · Read more »
Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy
05-15-2007 · EurekAlert!
Hormone replacement therapy (HRT) can reduce many cardiovascular disease (CVD) risks, but many women have stopped using HRT due to reports that HRT may increase the risk of breast cancer and heart disease. In a study published in the June issue of the American Journal of Preventive Medicine, researchers from the University of Pittsburgh Graduate School of Public Health examined whether the increased CVD risk from stopping HRT could be minimized by lifestyle change intervention.
Similar news · Read more »
Combined HRT increases risk of lobular breast cancer fourfold after just 3 years of use
01-15-2008 · EurekAlert!
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers at Fred Hutchinson Cancer Research Center.
Similar news · Read more »
Soy estrogens and breast cancer: Researcher offers overview
05-16-2007 · EurekAlert!
Are soy products healthy additions to a person’s diet, safe alternatives to hormone-replacement therapy or cancer-causing agents? The answer, according to University of Illinois food science and human nutrition professor William Helferich, is, "It depends."
Similar news · Read more »
Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients
10-15-2007 · EurekAlert!
Mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal cancer when comparing cases and controls. Patients with IBD are at significantly higher than average risk for colorectal cancer and should be screened more frequently, but another study revealed many don't get recommended tests.
Similar news · Read more »
Hip size of mothers linked to breast cancer in daughters
10-08-2007 · EurekAlert!
In a study of the maternity records of more than 6,000 women, David J.P. Barker, M.D., Ph.D., and Kent Thornburg, Ph.D., of Oregon Health & Science University discovered a strong correlation between the size and shape of a woman's hips and her daughter's risk of breast cancer. Wide, round hips, the researchers postulated, represent markers of high sex hormone concentrations in the mother, which increase her daughter's vulnerability to breast cancer.
Similar news · Read more »